We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Methods Assessed for Detecting Asymptomatic Malaria

By LabMedica International staff writers
Posted on 03 May 2017
Asymptomatic malaria infection refers to malarial parasitemia of any density in the absence of fever or other acute symptoms in individuals who have not received recent antimalarial treatments.

Sensitive methods for detecting asymptomatic malaria infections are essential for identifying potential transmission reservoirs and obtaining an accurate assessment of malaria epidemiology in low-endemicity areas aiming to eliminate malaria. More...
Polymerase chain reaction (PCR) techniques to detect parasite nucleic acids (DNA or RNA) are among the most commonly used molecular methods.

Scientists at China Medical University and their colleagues recruited 1,005 healthy individuals (344 males and 661 females, ages 1–82 years) living in Kachin Sate, Myanmar between May and November, 2015. Two fingerprick samples were taken, one was processed in a nearby field laboratory, and the other on filter paper, dried and stored. The study compared three molecular detection methods side-by-side, namely nested PCR targeting the ribosomal ribonucleic acid (rRNA) genes, nested RT-PCR to detect parasite rRNA, and capture and ligation probe-PCR (CLIP-PCR) to detect parasite RNA.

Thick and thin blood films stained with Giemsa were prepared and read. For positive slides, parasite density was quantified in 500 white blood cells (WBCs) on thick blood films assuming that 1 µL of blood contains 8,000 WBCs. Total RNA and genomic DNA were extracted from peripheral blood samples. Modified nested PCR (nD-PCR) was performed based on the 18S rRNA gene. For the CLIP-PCR 3-mm circle of dried blood spot on 3 M Whatman filter paper was punched out and lysed with 100-µL lysis mixture. Two RT-PCR methods were used to detect Plasmodium vivax gametocytes in samples. For detection of P. vivax gametocytes in all 1,005 samples, the 645 bp full-length Pvs25 gene was amplified using Pvs25-specific primers. Amplification and detection were performed on an ABI 7500 apparatus.

Light microscopy detected Plasmodium infections in only 1.19% of the residents harboring the parasites. CLIP-PCR had slightly better performance and detected Plasmodium infections in 1.89% of the population. Further improvement was achieved by nested PCR to detect parasite DNA, which detected P. vivax and P. falciparum infections in 2.39% of the residents. The nested RT-PCR targeting rRNA, however, detected as many as 187 (18.61%) individuals having Plasmodium infections with P. vivax being the predominant species (176 P. vivax, five P. falciparum and six P. falciparum/P. vivax mixed infections). Of the 210 Plasmodium-positive samples detected by all molecular methods, 115 were Pvs25-positive by quantitative polymerase chain reaction (qRT-PCR), indicating that a large proportion of asymptomatic individuals were gametocyte carriers.

The authors concluded that Nested RT-PCR based on the detection of asexual-stage parasite rRNA was the most sensitive, with a more than six-fold higher sensitivity than the other two molecular methods of parasite detection. CLIP-PCR has an increased throughput, but its sensitivity in this study was much lower than those of other molecular methods. The study was published on April 20, 2017, in the Malaria Journal.


Gold Member
Automatic Hematology Analyzer
CF9600
Online QC Software
Acusera 24•7
POC Immunoassay Analyzer
Procise DX
Clinical Informatics Platform
CLARION™
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The approach supports myocardial infarction diagnosis in resource-limited settings by reducing delays between clinical suspicion and biochemical confirmation (Image Credit: Adobe Stock)

Portable Troponin Assay Brings Heart Attack Diagnosis Closer to Patients

Timely confirmation of myocardial infarction often depends on laboratory testing that may not be immediately available at the point of care. This gap between clinical suspicion and definitive evidence... Read more

Microbiology

view channel
Image: An innovative countywide program in Taiwan combines risk-based screening with decentralized community care to improve hepatitis C detection and treatment (Image Credit: iStock)

Precision Screening Helps Close Hepatitis C Diagnosis and Treatment Gaps

Hepatitis C remains a leading cause of cirrhosis and liver cancer, yet many infections go undiagnosed or untreated because health systems fail to reach those at greatest risk. Although highly effective... Read more

Pathology

view channel
Image: Through the PCCP, Proscia gains a more efficient pathway to expand Concentriq AP-Dx interoperability while maintaining regulatory oversight (Photo courtesy of Proscia)

FDA-Cleared Digital Pathology Platform Expands Interoperability for Primary Diagnosis

Rising cancer incidence is colliding with a shrinking pathologist workforce, intensifying pressure on diagnostic turnaround times in clinical laboratories. Many labs are adopting digital pathology to manage... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.